MARY ANN LIEBERT, INC

• 

  Publisher Of

  • Correction to: Natural History, Predictors of Outcome, and Effects of Treatment in Thoracic Spinal Cord Injury: A Multi-Center Cohort Study from the North American Clinical Trials Network by Wilson, J.R. et al. J. Neurotrauma 2018;35(21):2554–2560. (DOI: 10.1089/neu.2017.5535).  Journal of Neurotrauma.  37:906-906. 2020
  • AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.  Human Gene Therapy.  30:139-154. 2019
  • Laparoscopic In Situ Dismembered Pyeloplasty as a Modified Technique to Facilitate Suturing and Alignment During Laparosopic Pyeloplasty: A Video Demonstration 2018
  • Initial Report of Sentinel Lymph Node Identification During Laparoscopic Radical Hysterectomy Using a New Gamma Probe Technology.  Journal of Laparoendoscopic and Advanced Surgical Techniques.  28:864-866. 2018
  • Laparoscopic In Situ Dismembered Pyeloplasty Can Facilitate Laparoscopic Ureteropelvic Junction Obstruction Repair: A Prospective Cohort Trial.  Journal of Endourology.  32:218-222. 2018
  • Artificial Neural Network System to Predict the Postoperative Outcome of Percutaneous Nephrolithotomy.  Journal of Endourology.  31:461-467. 2017
  • Evaluating the Repertoire of Immune Checkpoint Markers Expressed Within Ovarian Cancers.  Journal of Women'S Health (2002).  25:962-962. 2016
  • Identification and Therapeutic Inhibition of Pathways Driving Resistance to Targeted Breast Cancer Therapies.  Journal of Women'S Health (2002).  25:976-976. 2016
  • A Rotifer-Based Technique to Rear Zebrafish Larvae in Small Academic Settings.  Zebrafish.  13:281-286. 2016
  • Consistency of Quantitative Scores of Hypoglycemia Severity and Glycemic Lability and Comparison with Continuous Glucose Monitoring System Measures in Long-Standing Type 1 Diabetes.  Diabetes Technology & Therapeutics.  17:235-242. 2015
  • Changes in Gene Expression After Radiation in Human Breast Cancers: A Guide to Predicting and Modulating Radiation Response.  Journal of Women'S Health (2002).  23:861-861. 2014
  • A Multilevel Investigation of the Predictors of Mental Health in Midlife and Older Women: Results from the Australian Longitudinal Health Aging of Women Study.  Journal of Women'S Health (2002).  23:37-37. 2014
  • A Systematic Review of Weight Loss, Physical Activity, and Dietary Interventions Involving African American Men.  Journal of Men'S Health.  11:A32-A32. 2014
  • Up-regulation of Fas Expression in Human Breast Carcinomas Treated With Preoperative Radiation.  Journal of Women'S Health (2002).  22:890-890. 2013
  • Author's Response to Mandal et al..  Journal of Endourology.  27:1174-1175. 2013
  • Relationships Among HIV Infection, Metabolic Risk Factors, and Left Ventricular Structure and Function.  Aids Research and Human Retroviruses.  29:1151-1160. 2013
  • Comparison of Population and 454 “Deep” Sequence Analysis for HIV Type 1 Tropism Versus the Original Trofile Assay in Non-B Subtypes.  Aids Research and Human Retroviruses.  29:979-984. 2013
  • Laparoscopic Anatrophic Nephrolithotomy for Management of Complete Staghorn Renal Stone: Clinical Efficacy and Intermediate-Term Functional Outcome.  Journal of Endourology.  27:573-578. 2013
  • A Gender-Specific Blood-Based Gene Expression Score for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients: Results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) Trial.  Journal of Women'S Health (2002).  22:8-8. 2013
  • Differential Activation of Cell Death Pathways After Ionizing Radiation in Luminal and Basal Breast Cancer Cell Lines.  Journal of Women'S Health (2002).  21:992-992. 2012
  • Systemic Immunologic and Inflammatory Response After Laparoscopic Versus Open Nephrectomy: A Prospective Cohort Trial.  Journal of Endourology.  26:1231-1236. 2012
  • Laboratory-Developed Test—SynFRAME: An Approach for Assessing Laboratory-Developed Tests Synthesized from Prior Appraisal Frameworks.  Genetic Testing and Molecular Biomarkers.  16:605-614. 2012
  • Redox Control of 20S Proteasome Gating.  Antioxidants & Redox Signaling.  16:1183-1194. 2012
  • Gene Expression Response of Luminal and Basal Breast Cancer Cell Lines to Ionizing Radiation.  Journal of Women'S Health (2002).  20:1404-1405. 2011
  • MSH-releasing Inhibitor Factor (pro-leu-gly-NH2) Acts as an Allosteric Activator for Oxytocin-induced MAPK Signaling but Does Not Affect Uterine Contractility.  Journal of Women'S Health (2002).  20:1392-1392. 2011
  • Renal Parenchymal Damage After Percutaneous Nephrolithotomy with One-Stage Tract Dilation Technique: A Randomized Clinical Trial.  Journal of Endourology.  25:927-931. 2011
  • Levels and Predictors of Unmet Social Support for Healthy Behaviors Among Overweight and Obese Postpartum Women: Results from the Active Mothers Postpartum Study.  Journal of Women'S Health (2002).  20:459-460. 2011
  • Hybrid Natural Orifice Transluminal Endoscopic Surgery for Nephrectomy with Standard Laparoscopic Instruments: Experience in a Canine Model.  Journal of Endourology.  23:1985-1989. 2009
  • Clinical Q&A.  Bariatric Nursing and Surgical Patient Care.  4:229-232. 2009
  • Bolsterless Laparoscopic Partial Nephrectomy: A Simplification of the Technique.  Journal of Endourology.  23:965-969. 2009
  • Clinical Q&A.  Bariatric Nursing and Surgical Patient Care.  4:61-65. 2009
  • Many of my patients need to decrease their portion sizes in preparation for surgery. Likewise, some of my post weight-loss surgery patients struggle with the tendency to gradually increase portion sizes as the time from surgery lengthens. Are there behavioral strategies that I can suggest to patients that will facilitate their choosing and consuming smaller portions?.  Bariatric Nursing and Surgical Patient Care.  4:62-63. 2009
  • Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid.  Aids Research and Human Retroviruses.  25:207-212. 2009
  • Cesarean Delivery on Maternal Request Versus Planned Vaginal Delivery: A Decision Analysis To Identify Important Outcomes and To Prioritize Future Research Directions.  Journal of Women'S Health (2002).  17:1249-1249. 2008
  • A significant percentage of weight loss surgery patients complain that they have difficulty maintaining their motivation to exercise. Are there any techniques that I might use to enhance their motivation?.  Bariatric Nursing and Surgical Patient Care.  3:168-169. 2008
  • PC-FACS.  Journal of Palliative Medicine.  11:258-261. 2008
  • One-Stage Tract Dilation for Percutaneous Nephrolithotomy: Is It Justified?.  Journal of Endourology.  21:1415-1420. 2007
  • PC-FACS.  Journal of Palliative Medicine.  10:1425-1430. 2007
  • How to Improve the Safety of Polymer Clips for Vascular Control during Laparoscopic Donor Nephrectomy.  Journal of Endourology.  21:1319-1322. 2007
  • Clinical Q & A.  Bariatric Nursing and Surgical Patient Care.  2:153-156. 2007
  • What body image changes typically occur after weight loss?.  Bariatric Nursing and Surgical Patient Care.  2:154-155. 2007
  • Left-Sided Inferior Vena Cava Found Incidentally During Laparoscopic Donor Nephrectomy: Report of Three Cases.  Journal of Endourology.  21:542-544. 2007
  • Clinical Q & A.  Bariatric Nursing and Surgical Patient Care.  1:293-297. 2006
  • Virtual reality intervention for chemotherapy symptoms.  Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society.  9:717-718. 2006
  • Arterial thromboembolism in pregnancy: A United States population-based study.  Journal of Women'S Health (2002).  15:688-688. 2006
  • What is "Mindful Eating" and how can it help postoperative weight loss surgery patients?.  Bariatric Nursing and Surgical Patient Care.  1:144-144. 2006
  • The pandemic threat of avian influenza: An update for health care professionals.  Journal of Women'S Health (2002).  15:460-460. 2006
  • What psychosocial issues can delay or preclude a patient from having weight loss surgery?.  Bariatric Nursing and Surgical Patient Care.  1:65-65. 2006
  • Mouse Strain Differences in the Chemokine Response to Acute Lung Infection with a Murine Gammaherpesvirus.  Viral Immunology.  17:69-77. 2004
  • Impact Mechanics and Axonal Injury in a Sheep Model.  Journal of Neurotrauma.  20:961-974. 2003
  • Characterization of Multiple CD34+Cell Populations in Cord Blood.  Journal of Hematotherapy & Stem Cell Research.  12:199-213. 2003
  • Safety Testing for Replication-Competent Retrovirus Associated with Gibbon Ape Leukemia Virus-Pseudotyped Retroviral Vectors.  Human Gene Therapy.  12:61-70. 2001
  • Patient Satisfaction with Telemedicine.  Telemedicine Journal.  6:5-13. 2000
  • Recombinant Bacillus Calmette-Guerin as a Potential Vector for Preventive HIV Type 1 Vaccines.  Aids Research and Human Retroviruses.  16:91-98. 2000
  • Expression of Naked Plasmid DNA Injected into the Afferent and Efferent Vessels of Rodent and Dog Livers.  Human Gene Therapy.  8:1763-1772. 1997
  • Diastolic ventricular morphometry: Analysis of polymeric and paraffin casting.  Journal of Cardiovascular Diagnosis and Procedures.  13:285-285. 1996
  • Effect of subacute pressure overload and release on RV relaxation and filling patterns.  Journal of Cardiovascular Diagnosis and Procedures.  13:295-295. 1996
  • Geometric modeling of the right ventricle and CFD simulation of the early diastolic inflow.  Journal of Cardiovascular Diagnosis and Procedures.  13:296-296. 1996
  • New methods for assessment of RV relaxation and pressure-volume relations.  Journal of Cardiovascular Diagnosis and Procedures.  13:294-294. 1996
  • Collagen?GAG Scaffolds Grafted onto Myocardial Infarcts in a Rat Model: A Delivery Vehicle for Mesenchymal Stem Cells.  Tissue Engineering.  0:060913044658014-060913044658014.
  • Robot-Assisted Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy.  Journal of Laparoendoscopic & Advanced Surgical Techniques Part B, Videoscopy. 
  • Tantrum Tool: Development and Open Pilot Study of Online Parent Training for Irritability and Disruptive Behavior.  Journal of Child and Adolescent Psychopharmacology. 
  • Tapered Polymer Whiskers to Enable Three-Dimensional Tactile Feature Extraction.  Soft Robotics. 
  • THE CROES GREENLIGHT STUDY DATA AUDIT: AN EXPERIENCE IN INTERNATIONAL CLINICAL DATA AUDITING.  Journal of Endourology.  26:304-308. 2012
  • Comparison of comminution and stone clearance between intracorporeal lithotripters.  Journal of Endourology.  21:A237-A238. 2007
  • Association of Right Versus Left Hemisphere Stroke on Rehabilitation Outcomes.  Journal of Women'S Health (2002). 1588-1589. 2019
  • DIFFERENT HOSPITAL, DIFFERENT INTERVENTION? PREDICTORS OF SURGICAL INTERVENTION AND OUTCOMES IN TRAUMATIC SPINAL CORD INJURY.  Journal of Neurotrauma. A66-A67. 2019
  • A COMPUTATIONAL ANALYSIS OF AEROSOL DEPORTATION IN LARYNGOTRACHEAL STENOSIS.  Journal of Aerosol Medicine and Pulmonary Drug Delivery. A10-A10. 2019
  • Patient-specific iPSC-derived endothelial cells provide longterm phenotypic correction of hemophilia A.  Human Gene Therapy. A78-A78. 2018
  • Zero incidence of adeno-associated virus serotype 9 (AAV9) antibodies in a cohort of spinal muscular atrophy (SMA) type 1 patients screened in STR1VE, a pivotal phase 3 study of AVXS-101.  Human Gene Therapy. A82-A83. 2018
  • Financial Burden Related to Decisions for Breast Cancer Surgery.  Journal of Women'S Health (2002). 1422-1423. 2018
  • Using Digital Health to Improve Adoption of the Dietary Approaches to Stop Hypertension (DASH) Diet.  Journal of Women'S Health (2002). 1429-1430. 2018
  • Assessment of the Frequency of VRC01 Class Naive B Cells in Different Populations That Can Potentially Engage an HIV CD4 Binding Site Immunogen.  Aids Research and Human Retroviruses. 109-109. 2018
  • Bridging Vaccine-induced Antibody Responses in Rabbit and Rhesus Macaque Animal Models.  Aids Research and Human Retroviruses. 129-129. 2018
  • Characterizing Env-specific Monoclonal Antibodies Isolated From US and Malawian HIV-infected Non-transmitting and Transmitting Women.  Aids Research and Human Retroviruses. 390-390. 2018
  • Chimpanzee SIV Envelope-derived Trimer Guides an Immunofocused HIV Cross-neutralizing Ab Response in V2-apex bnAb UCA Expressing Knock-in Mice.  Aids Research and Human Retroviruses. 60-60. 2018
  • Co-administration of 3 Doses of DNA/Protein Improves Antibody Responses to a Prime-boost Approach, but Needle-free Injection of DNA Shows No Benefit.  Aids Research and Human Retroviruses. 337-337. 2018
  • Cross-clade ADCC Activities in Human Volunteer Sera Elicited by a Polyvalent DNA Prime-protein Boost HIV Vaccine DP6-001.  Aids Research and Human Retroviruses. 129-129. 2018
  • DNA-prime Induces Higher Magnitude Humoral Responses Than ALVAC-prime in HIV Vaccine Regimens With the Same Protein Boost.  Aids Research and Human Retroviruses. 17-17. 2018
  • Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk.  Aids Research and Human Retroviruses. 88-88. 2018
  • Determinants of Transplacental Transfer of Protective Maternal IgG in HIV-infected Women.  Aids Research and Human Retroviruses. 339-339. 2018
  • Development of Neutralizing Antibody Responses in SHIV CH505-infected Adult and Infant Rhesus Macaques.  Aids Research and Human Retroviruses. 250-250. 2018
  • Dual Maturation Pathways from the Unmutated Common Ancestor of HIV-1 Envelope Broadly Neutralizing Antibodies Overcome Glycan Barriers.  Aids Research and Human Retroviruses. 111-111. 2018
  • Expansion of VH1-2*02 Env-specific B Cells in a Non-neutralizing HIV-1 Env Vaccine Regimen.  Aids Research and Human Retroviruses. 109-109. 2018
  • Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA With or Without CN54rgp140/GLA-AF in Healthy Tanzanian and Mozambican Volunteers.  Aids Research and Human Retroviruses. 119-120. 2018
  • Germline-targeting and Reverse Engineering to Elicit CH235.12 Lineage bNAbs.  Aids Research and Human Retroviruses. 116-116. 2018
  • Glycoengineering HIV-1 Env Creates "Supercharged" and "Hybrid" Glycans to Increase Neutralizing Antibody Potency, Breadth and Saturation.  Aids Research and Human Retroviruses. 113-113. 2018
  • HIV Neutralizing Antibodies Induced by Native-like Envelope Trimers Incorporated Into a Rhabdoviral Vector Vaccine.  Aids Research and Human Retroviruses. 324-324. 2018
  • HVTN114: A Phase 1 Trial to Evaluate Late Boosts With AIDSVAX B/E of Participants Previously Vaccinated With MVA/HIV62B in DNA/MVA or MVA Regimens.  Aids Research and Human Retroviruses. 184-184. 2018
  • Higher HIV Neutralization Breadth in Young Children Than in Chronically Infected Adults.  Aids Research and Human Retroviruses. 125-125. 2018
  • Immune Responses to PENNVAX-GP (R) HIV DNA Vaccine Plus IL-12 Are Equivalent or Superior When Delivered by Intradermal vs. Intramuscular Electroporation.  Aids Research and Human Retroviruses. 45-45. 2018
  • Impact of Vaccine Regimen on Vaccine-induced Antibody Durability.  Aids Research and Human Retroviruses. 88-88. 2018
  • Increase in Env-specific Binding Antibody and CD4+T Cell-responses After Month 30 Boost of gp120/MF59 Delivered Alone or With ALVAC-HIV.  Aids Research and Human Retroviruses. 90-90. 2018
  • Increased Breadth of T-cell Responses After Mosaic HIV Vaccination in Humans (HVTN 106).  Aids Research and Human Retroviruses. 31-31. 2018
  • Induction of Neutralizing Antibodies Against Autologous Viruses in HIV-1 Infected Pregnant Women Immunized With a gp120/160 Vaccine.  Aids Research and Human Retroviruses. 393-393. 2018
  • Macaque SHIV Induction of 2G12-like Broadly Neutralizing Antibodies.  Aids Research and Human Retroviruses. 38-38. 2018
  • Mechanistic Insights Into Vaccine Induction of V2 Apex-directed, Heterologous Tier 2 Neutralizing Responses in CH103 UCA Knock-in Mice.  Aids Research and Human Retroviruses. 110-110. 2018
  • Neutralization Potency Can Account for the Majority of Antibody-mediated Protection Observed in ex vivo Vaginal Explant Models of Early HIV Infection.  Aids Research and Human Retroviruses. 302-302. 2018
  • Neutralizing and ADCC Activity of Anti-HIV-1 Antibodies Against Acute Subtype C Envs: Implications for Prevention and Treatment of HIV-1 Infection.  Aids Research and Human Retroviruses. 53-53. 2018
  • New SHIV Models of bNAb Elicitation and Env-Ab Coevolution.  Aids Research and Human Retroviruses. 21-21. 2018
  • Outcomes for PrEP Users in the Southern US: Persistence and STIs.  Aids Research and Human Retroviruses. 258-258. 2018
  • Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens.  Aids Research and Human Retroviruses. 18-18. 2018
  • Prolonged Intervals Between Boosts Induces High Magnitude Transient V2-specific Functional Antibodies That Inhibit the Binding of V2 to alpha 4 beta 7 Integrin.  Aids Research and Human Retroviruses. 127-127. 2018
  • Recognition and Elimination of HIV-1-infected Cells by ADCC-mediating mAbs for Prevention and Treatment of HIV-1 Infection.  Aids Research and Human Retroviruses. 126-126. 2018
  • Recombinant MVA Prime Elicits Neutralizing Antibody Responses by Inducing Antigen-specific B Cells in the Germinal Center.  Aids Research and Human Retroviruses. 74-74. 2018
  • Safety and Immunogenicity of a pDNA Clade B Env Prime, rVSV Clade C Env Boost HIV-1 Vaccination Regimen in a Phase 1 Clinical Trial.  Aids Research and Human Retroviruses. 16-16. 2018
  • Structural Basis for A32-like Epitopes Involved in ADCC Response of the RV114 Vaccine Trial.  Aids Research and Human Retroviruses. 114-114. 2018
  • Targeted Selection of an Improbable HIV-1 Antibody Mutation Critical for Broadly Neutralizing Reactivity With a Designed Immunogen.  Aids Research and Human Retroviruses. 58-58. 2018
  • Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine.  Aids Research and Human Retroviruses. 187-187. 2018
  • Therapeutic Vaccination With a Combination of IDLV-SIV-Gag and IDLV-PGT121 Results in Prolonged Virus Control in Chronically SHIV-infected Macaques.  Aids Research and Human Retroviruses. 50-50. 2018
  • V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa.  Aids Research and Human Retroviruses. 17-17. 2018
  • Vaccine Induction of V2 Apex-directed, Cross-reactive Neutralizing Antibodies in CH01 UCA "HC Only" Knock-in Mice.  Aids Research and Human Retroviruses. 121-121. 2018
  • Vaccine-induced Activation of Inflammasome in Classical Monocytes and Th2 Cell Responses Correlates With Decreased Risk of SIVmac251 Acquisition.  Aids Research and Human Retroviruses. 73-73. 2018
  • THE EFFECT OF RILUZOLE ON INTRAMEDULLARY LESION LENGTH AND DTI, RATIONALE AND DESIGN OF RISCIS MRI-SUBSTUDY.  Journal of Neurotrauma. A165-A165. 2018
  • UNDERSTANDING DECISIONS TO UNDERSTAND OUTCOMES: FACTORS PREDICTING SURGERY FOLLOWING SEVERE TRAUMATIC BRAIN INJURY.  Journal of Neurotrauma. A279-A280. 2018
  • 3D Tissue-engineered Model of Pressure-overload Induced Cardiac Fibrosis.  Tissue Engineering. Part A. S64-S64. 2017
  • Combined Drug and Electrical Stimulation Synergistically Increase Function of Engineered Human Skeletal Muscle.  Tissue Engineering. Part A. S39-S40. 2017
  • Contractile hPSC derived Skeletal Muscle Tissues for Human Disease Modeling.  Tissue Engineering. Part A. S128-S128. 2017
  • Development of a Human Tissue-Engineered Model of Duchenne Muscular Dystrophy.  Tissue Engineering. Part A. S115-S115. 2017
  • In Situ Monitoring of Engineering Muscle to Assess Myopathy.  Tissue Engineering. Part A. S117-S117. 2017
  • In Vitro Bioengineered Model for Studies of Human Muscle Regeneration.  Tissue Engineering. Part A. S71-S71. 2017
  • Platelet-Like-Particles Mediate Matrix Properties to Promote Cell Migration in a Hemophilia Wound Healing Model.  Tissue Engineering. Part A. S11-S11. 2017
  • Skeletal Muscle-Macrophage Platform for Modeling Tissue Regeneration.  Tissue Engineering. Part A. S9-S9. 2017
  • Tissue-Engineered Human Skeletal Muscle Model of Rheumatoid Arthritis.  Tissue Engineering. Part A. S82-S82. 2017
  • Tissue-engineered Cardiobundles for In Vitro Development of Heart Regeneration Therapies.  Tissue Engineering. Part A. S2-S2. 2017
  • Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes.  Human Gene Therapy. A12-A12. 2017
  • The Financial Burden of Breast Cancer Treatment.  Journal of Women'S Health (2002). 1022-1022. 2017
  • Statin Responses within a Human Vascular Microphysiological System under Inflammatory Conditions.  Tissue Engineering. Part A. S23-S23. 2016
  • Development of AAV-shRNA vectors for human basal-like breast cancer therapy.  Human Gene Therapy. A88-A88. 2016
  • Comparing Different Priming Strategies to Optimize HIV Vaccine Antibody Responses: Results from HVTN 096/EV04 (NCT01799954).  Aids Research and Human Retroviruses. 68-68. 2016
  • DNA and Protein Co-delivery Vaccines Using TLR-4-based Adjuvants Induce Potent Immune Responses Able to Delay Heterologous SIV Acquisition.  Aids Research and Human Retroviruses. 67-67. 2016
  • DNA/MVA HIV Vaccine Producing Virus-like Particles (VLPs) Is Well-tolerated and Induces Durable Functional Antibodies (Abs) in HVTN 094.  Aids Research and Human Retroviruses. 99-99. 2016
  • Deterministic Compartment PK Model for Rectal Tenofovir (TFV) Delivery by an Enema.  Aids Research and Human Retroviruses. 303-303. 2016
  • Deterministic Compartmental Pharmacokinetic Model for an Intravaginal Ring (IVR).  Aids Research and Human Retroviruses. 303-303. 2016
  • EV06 Trial: Modulation of the Immunogenicity of the DNA-HIV-PT123 and AIDSVAX (R) B/E combination HIV vaccine in adult Ugandans by S. mansoni Infection.  Aids Research and Human Retroviruses. 110-110. 2016
  • Effects of gp140 Protein Booster Immunizations to DNA/MVA SHIV Vaccine on Immunogenicity and Protection against Intravaginal Tier-2 SHIV Challenges.  Aids Research and Human Retroviruses. 347-347. 2016
  • Features of Recently Transmitted HIV-1 Clade C Viruses That Impact Antibody Recognition: Implications for Active and Passive Immunization.  Aids Research and Human Retroviruses. 261-261. 2016
  • HIV-1 MPER-directed Broadly Neutralizing Antibodies from an Acute-infection Cohort RV217 Subject.  Aids Research and Human Retroviruses. 36-36. 2016
  • Infant Peripartum Transmitted-founder HIV-1 Variants are Resistant to Autologous Maternal Plasma Neutralization.  Aids Research and Human Retroviruses. 87-87. 2016
  • Initiation of Neutralizing Antibody B Cell Lineages by HIV Vaccine Candidates.  Aids Research and Human Retroviruses. 18-18. 2016
  • MVA-expressed gp140 Boosts More Durable V1/V2 and gp120 Antibody Responses than gp120 Protein in Alum.  Aids Research and Human Retroviruses. 59-59. 2016
  • Measuring Sensory Experiences Elicited by Product Properties During Receptive Anal Sex: Implications for Prevention Design and Marketing.  Aids Research and Human Retroviruses. 156-156. 2016
  • Mucin-binding IgG: Characterizing a Novel Antibody Effector Function and Discovery of a New Fc Receptor.  Aids Research and Human Retroviruses. 112-112. 2016
  • Overview of Humoral and Cellular Immune Responses to HIV Vaccination.  Aids Research and Human Retroviruses. 14-14. 2016
  • Partial Protection from Intravenous Challenge by an Integration-defective SIV Vaccine.  Aids Research and Human Retroviruses. 325-325. 2016
  • Prevention of Vaginal Transmission of Simian-Human Immunodeficiency Virus (SHIV) in Rhesus Monkeys by Small-molecule CD4-mimetic Compounds.  Aids Research and Human Retroviruses. 129-129. 2016
  • Protection from Rectal SHIV Infection Induced by Mucosal Vaccination with a Replication-competent VSV-HIV Chimera Delivering Env Trimers.  Aids Research and Human Retroviruses. 18-18. 2016
  • Role of Adjuvants in Enhancing Durability of HIV Vaccine Responses by Inducing Potent Germinal Centers and Plasma Cell Responses.  Aids Research and Human Retroviruses. 30-30. 2016
  • Selective Activation of VRC01-class Germline Antibodies in Knock-in Mice with Diverse Precursor Repertoires.  Aids Research and Human Retroviruses. 124-124. 2016
  • Synthetic Biocompatible Polymers Are an Effective Delivery Platform That Elicits Potent Antibody Responses Against HIV-1 Glycopeptide Immunogens.  Aids Research and Human Retroviruses. 221-221. 2016
  • The Relationship between Immune Responses to Tetanus Vaccine, Hepatitis B Vaccine and a Pox-protein HIV Vaccine Regimen.  Aids Research and Human Retroviruses. 76-76. 2016
  • Variable IgG Transplacental Transfer in the Setting of Maternal HIV Infection.  Aids Research and Human Retroviruses. 92-92. 2016
  • INFILTRATION OF MACROPHAGES PROMOTES INFLAMMATION RAPIDLY AT EPICENTER AND REMOTE REGIONS AFTER THORACIC SCI.  Journal of Neurotrauma. A50-A50. 2016
  • Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components.  Human Gene Therapy. A3-A4. 2015
  • Anatomically-Shaped Tissue-Engineered Cartilage with Tunable and Inducible Anti-Inflammatory Capabilities.  Tissue Engineering. Part A. S330-S330. 2015
  • CRISPRi Immunomodulation for Tissue Engineering/Stem Cell Therapies Targeting Intervertebral Disc Degeneration.  Tissue Engineering. Part A. S170-S170. 2015
  • Development of a Polycaprolactone (PCL) Scaffold as a Platform for Human Corneal Stroma Regeneration.  Tissue Engineering. Part A. S218-S219. 2015
  • Engineering Regenerative Skeletal Muscle Tissues.  Tissue Engineering. Part A. S310-S310. 2015
  • Evaluation of Poly (carbonate-urethane) Urea (pcuu) as a Urinary Bladder Tissue Engineering Scaffold.  Tissue Engineering. Part A. S173-S174. 2015
  • Fabrication of Scaffold-free Tissue Engineered Blood Vessel using Nanopatterned Human Mesenchymal Stem Cell Sheet.  Tissue Engineering. Part A. S271-S271. 2015
  • Human Tissue Engineered Blood Vessels for in vitro Drug Testing.  Tissue Engineering. Part A. S318-S318. 2015
  • Novel In Vitro Exercise Model of Engineered Human Skeletal Muscle.  Tissue Engineering. Part A. S46-S46. 2015
  • Transdifferentiation of Human Endothelial Progenitors into Functional Smooth Muscle Cells Following Induction with the Transcriptional Co-Activator MYOCD for Tissue Engineering Applications.  Tissue Engineering. Part A. S141-S142. 2015
  • REMOTE BLOOD BRAIN BARRIER DISRUPTION AFTER MID-THORACIC SPINAL CORD INJURY.  Journal of Neurotrauma. A142-A143. 2015
  • African Early Infection Cohort as a Platform for Vaccine Discovery: The IAVI Protocol C Experience.  Aids Research and Human Retroviruses. A31-A31. 2014
  • An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults.  Aids Research and Human Retroviruses. A17-A17. 2014
  • Antiretroviral Pre-exposure Prophylaxis and Risk of Decreased Glomerular Filtration Rate among HIV Uninfected Men and Women.  Aids Research and Human Retroviruses. A162-A162. 2014
  • DuoGel™: The Development of A Multi-drug Dual Chamber Vaginal/Rectal Anti-HIV Microbicide Gel.  Aids Research and Human Retroviruses. A148-A148. 2014
  • HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults.  Aids Research and Human Retroviruses. A33-A34. 2014
  • Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes.  Aids Research and Human Retroviruses. A40-A40. 2014
  • Microbicide-vaccine Combination Provides Significant Protection against Vaginal SHIV-162P3 Challenge in Cynomolgous Monkeys.  Aids Research and Human Retroviruses. A26-A26. 2014
  • No Increase in Activated T Cells and Limited Increase in Adenovirus-specific T Cells in Colon and Rectal Mucosa Following HIV-1 DNA/rAd5 Immunization.  Aids Research and Human Retroviruses. A48-A48. 2014
  • Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251.  Aids Research and Human Retroviruses. A20-A20. 2014
  • Utilizing Mucin-tethered HIV IgG to Enhance HIV Vaccine Function.  Aids Research and Human Retroviruses. A154-A154. 2014
  • THE INDO-US COLLABORATIVE HEAD INJURY AND ADHERENCE TO GUIDELINES (CHIRAG) PROJECT: OUTCOMES AND FEASIBILITY.  Journal of Neurotrauma. A23-A23. 2014
  • Hematopoietic stem cell gene therapy with lentiviral vector in 4 patients with cerebral X-linked adrenoleukodystrophy: long-term outcome and comparison of efficacy with allogeneic hematopoietic stem cell transplantation.  Human Gene Therapy. A21-A21. 2013
  • A Combined Saavi MVA-C and Novartis Gp140 Env Protein Vaccine Boost Elicits Robust HIV Cellular and Humoral Responses in a Nonhuman Primate Model.  Aids Research and Human Retroviruses. A39-A39. 2013
  • A Late Third HIV-MVA Vaccination Boosted Strong and Potent Immune Responses in Tanzanian Volunteers Previously Immunized with HIV-DNA and HIV-MVA.  Aids Research and Human Retroviruses. A174-A174. 2013
  • A Single Immunization with Integrase Defective Lentiviral Vector Expressing gp140 Induces Persistent and Functional Immune Response in Rhesus Monkeys.  Aids Research and Human Retroviruses. A161-A161. 2013
  • Alum and MF59, in Combination with ALVAC-SIV and Gp120 Vaccines Recruit Functionally Different NK Cells to the Gut of Vaccinated Rhesus Macaque.  Aids Research and Human Retroviruses. A100-A100. 2013
  • Antibody Repertoire Induced by the Multiclade (Env A, B, C) HIV-1 DNA Prime, rAd5 Boost VRC Vaccine.  Aids Research and Human Retroviruses. A9-A9. 2013
  • Association of Fc gamma RIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144.  Aids Research and Human Retroviruses. A178-A179. 2013
  • Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial.  Aids Research and Human Retroviruses. A171-A171. 2013
  • Combined Mucosal and Systemic C.1086 Envelope Immunization of Lactating Monkeys Induces Potent IgA and Functional IgG Antibody Responses in Milk.  Aids Research and Human Retroviruses. A180-A180. 2013
  • Comparable Antigenicity and Immunogenicity of Multimeric Forms of a Novel, Acute HIV-1 Subtype C Gp145 Envelope for Clinical Development.  Aids Research and Human Retroviruses. A30-A30. 2013
  • Comparative Evaluation of Assays for Fc Receptor-Mediated Antibody Effector Functions Targeting HIV-1.  Aids Research and Human Retroviruses. A169-A169. 2013
  • Development of an Early Stage Investigator Scholar Program for Preclinical Researchers.  Aids Research and Human Retroviruses. A33-A33. 2013
  • Distinct VH Gene Usage and HIV Envelope Specificity of Colostrum and Peripheral B Cell Monoclonal Antibodies of HIV-Infected, Lactating African Women.  Aids Research and Human Retroviruses. A169-A170. 2013
  • Eliminating Autoreactivity of Variants of Antibody VRC07 by Glycan Masking.  Aids Research and Human Retroviruses. A55-A55. 2013
  • Engineering a Next Generation VRC01-Like Antibody with Improved In Vitro and In Vivo Function.  Aids Research and Human Retroviruses. A48-A49. 2013
  • Env Binding to the alpha 4 beta 7 Integrin Complex Is Not a General Property of Most HIV-1 Variants.  Aids Research and Human Retroviruses. A100-A100. 2013
  • Exogenous Expression of HIV-1 Envelope Glycoprotein Trimer in Suspension Culture-Adapted HEK293 and CHO-K1 Cells.  Aids Research and Human Retroviruses. A190-A191. 2013
  • Genetic and Immunological Evidence for a Role of Env-V3 Antibodies in the RV144 Trial.  Aids Research and Human Retroviruses. A168-A168. 2013
  • HIV-1 Specific Binding Antibody Titres in Blood Predict Detection in the Female Genital Tract in Women Who Became Infected in the CAPRISA 004 Microbicide.  Aids Research and Human Retroviruses. A101-A101. 2013
  • HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition.  Aids Research and Human Retroviruses. A178-A178. 2013
  • HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men.  Aids Research and Human Retroviruses. A172-A172. 2013
  • Heterogeneity of Anti-V2 ADCC Ab Responses and Implications for Vaccine Development.  Aids Research and Human Retroviruses. A41-A41. 2013
  • High Affinity Recognition of Synthetic Glycopeptides by HIV-1 gp120 V1V2 Loop Broadly Neutralizing Antibodies and Their Unmutated Common Ancestors.  Aids Research and Human Retroviruses. A185-A185. 2013
  • Human HIV-1 Vaccine Induced Antibody Durability and Env IgG3 Responses.  Aids Research and Human Retroviruses. A187-A187. 2013
  • In Vivo Targeting of HIV Gag to Dendritic Cells Given with Poly ICLC Is Safe and Induces Durable CD4 T Cell and B Cell Responses in Healthy Volunteers.  Aids Research and Human Retroviruses. A65-A65. 2013
  • Increased HIV-1 Immunogenicity of Replication Competent NYVAC.  Aids Research and Human Retroviruses. A160-A160. 2013
  • Intestinal Commensal Bacteria Shape the Pre-transmission Antibody Repertoire to HIV-1 Infection.  Aids Research and Human Retroviruses. A105-A105. 2013
  • Isolation and Characterization of an Autoreactive CD4bs Broad Neutralizing Antibody from a Chronic HIV-1 Controller with Systemic Lupus Erythematosus.  Aids Research and Human Retroviruses. A45-A46. 2013
  • Isolation of mAbs from Sorted Single B Cells by RT/PCR for Analysis of B Cell Responses to HIV-1 MPER Epitope in Vaccinated Rhesus Macaques.  Aids Research and Human Retroviruses. A30-A30. 2013
  • Lipid Components in MPER-Based Immunization Regimens Are Critical for Inducing Broadly Neutralizing Antibody Responses in 2F5 and 4E10 Knockin Mice.  Aids Research and Human Retroviruses. A20-A20. 2013
  • MF59 and ALUM, in Combination with an ALVAC-SIV/gp120 Vaccine, Induce Plasmablasts that Differ in the Expression of Homing Markers.  Aids Research and Human Retroviruses. A13-A13. 2013
  • Multiclade E-DNA Prime Enhances the Functional Antibody Response Induced by a Recombinant gp120 Boost in Non-human Primates.  Aids Research and Human Retroviruses. A38-A38. 2013
  • Multiple Pathways of HIV-1 Autologous Neutralizing Antibodies Cooperate to Drive CD4 Binding Site Broadly Neutralizing Antibody Responses.  Aids Research and Human Retroviruses. A186-A186. 2013
  • Optimization of Systemic and Mucosal Immune Responses to SIV and HIV-1 Antigens Using Different Protocols of DNA and Protein Immunization in Macaques.  Aids Research and Human Retroviruses. A19-A19. 2013
  • Phylogenetic Conservation of a Dominant Antibody Light Chain HIV Env V2 Binding Motif in Human and rhesus Macaque Antibodies.  Aids Research and Human Retroviruses. A168-A168. 2013
  • Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination.  Aids Research and Human Retroviruses. A39-A39. 2013
  • Protection from SIVmac251 Acquisition by an ALVAC/SIV/gp120 Regimen Is Not Improved by the Increase of Anti-Envelope Antibodies and T Cell Responses.  Aids Research and Human Retroviruses. A34-A34. 2013
  • Rhesus Full Length Single Chain (rhFLSC) Protects Rhesus Macaques from Heterologous Intrarectal Challenge with Multiple Low Doses of SHIV162P3.  Aids Research and Human Retroviruses. A40-A40. 2013
  • Structural Analysis of the Unmutated Common Ancestor Antibodies of the HIV Envelope V2 Antibodies CH58 and CH59 Derived from RV144 Vaccinees.  Aids Research and Human Retroviruses. A167-A168. 2013
  • Systemic IgG and IgA Responses to gp70V1V2 and C1 in HIV-Infected Elite Controllers Versus Controllers and Noncontrollers on HAART.  Aids Research and Human Retroviruses. A62-A62. 2013
  • Vaccine Induced Epitope Specific Antibodies to the SIV Envelope Are Distinct from Those Induced to the HIV-1 Envelope.  Aids Research and Human Retroviruses. A10-A11. 2013
  • A NOVEL MOUSE MODEL OF BLAST OF BLAST BRAIN INJURY: BLAST CONDITIONS SEEN IN THEATER.  Journal of Neurotrauma. A88-A89. 2013
  • A COMPUTATIONAL MESH DESIGN FOR AIRFLOW AND NEBULIZED PARTICLE TRANSPORT SIMULATION IN A SINONASAL MODEL AFTER FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS).  Journal of Aerosol Medicine and Pulmonary Drug Delivery. A37-A37. 2013
  • Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6.  Human Gene Therapy. A122-A122. 2012
  • COST COMPARISON OF SWL AND URS IN ACCOUNTABLE CARE ERA.  Journal of Endourology. A338-A338. 2012
  • COST- AND RADIATION DOSE-AWARENESS AMONG UROLOGY RESIDENTS: A SURVEY OF ATTITUDES AND EDUCATIONAL NEEDS.  Journal of Endourology. A418-A418. 2012
  • DOES THE MODALITY OF PREOPERATIVE IMAGING AFFECT THE OUTCOME OF PNL?.  Journal of Endourology. A199-A199. 2012
  • EFFECTS OF HOLMIUM: YAG LASER ENERGY SETTINGS ON FIBER TIP DEGRADATION.  Journal of Endourology. A25-A25. 2012
  • EFFECTS OF SODIUM AND FRUCTOSE INTAKE ON PEDIATRIC STONE FORMATION.  Journal of Endourology. A111-A111. 2012
  • EMERGENT URETERAL STENT VERSUS NEPHROSTOMY FOR UROSEPTIC CALCULI: UTILIZATION AND OUTCOMES OVER 15 YEARS.  Journal of Endourology. A231-A232. 2012
  • IMPACT OF NEPHROSTOMY TRACT LENGTH ON PNL OUTCOMES.  Journal of Endourology. A35-A35. 2012
  • OBESITY TRIPLES THE RADIATION EXPOSURE OF STONE PROTOCOL CT.  Journal of Endourology. A196-A197. 2012
  • OPTICAL PERFORMANCE COMPARISON OF DEFLECTABLE LAPAROSCOPES FOR LAPAROENDOSCOPIC SINGLE-SITE SURGERY.  Journal of Endourology. A37-A38. 2012
  • STONE FACTORS PREDICTING STONE FREE RATES IN PERCUTANEOUS NEPHROLITHOTOMY.  Journal of Endourology. A190-A190. 2012
  • WHAT IS THE ANTIBIOTIC OF CHOICE FOR OBSTRUCTING STONE PATIENTS WITH SEPSIS? A CONDITION-SPECIFIC ANTIBIOGRAM.  Journal of Endourology. A7-A8. 2012
  • ACOUSTIC RADIATION FORCE IMPULSE ULTRASOUND IMAGING FOR THE EVALUATION OF DISTAL URETERAL STONES IN A PHANTOM MODEL.  Journal of Endourology. A18-A19. 2011
  • ASSESSING THE EFFECTS OF RESPIRATORY MOTION ON STONE COMMINUTION DURING SWL IN AN IN VITRO MODEL.  Journal of Endourology. A290-A290. 2011
  • DETERMINATION OF PATIENT RADIATION DOSE DURING URETEROSCOPIC TREATMENT OF UROLITHIASIS USING A VALIDATED MODEL.  Journal of Endourology. A17-A17. 2011
  • IMAGING MODALITIES AND STONE-FREE RATES: RESULTS FROM THE CLINICAL RESEARCH OFFICE OF THE ENDOUROLOGICAL SOCIETY PERCUTANEOUS NEPHROLITHOTOMY GLOBAL STUDY.  Journal of Endourology. A115-A116. 2011
  • IN-VITRO ASSESSMENT OF A NEW PORTABLE BALLISTIC LITHOTRIPTER WITH PERCUTANEOUS AND URETEROSCOPIC MODELS.  Journal of Endourology. A101-A101. 2011
  • LESS PYELOPLASTY: A COMBINED LAPAROSCOPIC AND ROBOTIC APPROACH.  Journal of Endourology. A335-A336. 2011
  • ORGAN SPECIFIC RADIATION DOSE AND EFFECTIVE DOSE FOR RENAL STONE PROTOCOL CT.  Journal of Endourology. A18-A18. 2011
  • RADIATION EXPOSURE FROM NON-CONTRAST CT, DIGITAL TOMOSYNTHESIS, AND STANDARD KUB AND TOMOGRAMS.  Journal of Endourology. A304-A305. 2011
  • USE OF A NOVEL ANTI-RETROPULSION DEVICE FOR URETEROSCOPIC TREATMENT OF URETERAL STONES.  Journal of Endourology. A327-A327. 2011
  • 2F5-like Cross-Reactive HIV-1-Neutralizing Monoclonal Antibodies with Low Number of Somatic Mutations.  Aids Research and Human Retroviruses. A9-A9. 2011
  • A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens.  Aids Research and Human Retroviruses. A24-A25. 2011
  • ADCC Titers to HIV-Infected Cells Are Detectable in the Majority of Vaccine Recipients in the RV144 Trial.  Aids Research and Human Retroviruses. A20-A21. 2011
  • AN RNA APTAMER IS A POTENTIAL BIOMARKER FOR PANCREATIC CANCER.  Nucleic Acid Therapeutics. A40-A41. 2011
  • DNA and Protein Vaccination Confers Protection Upon Mucosal Challenge with Heterologous SIVsmE660.  Aids Research and Human Retroviruses. A24-A24. 2011
  • Detection of CD4-Binding Site Antibodies in Three HIV-1 Seroconverter Cohorts.  Aids Research and Human Retroviruses. A47-A47. 2011
  • Development of CAVD/EQAPOL Long-Term PBMC Repository ('07-'10) @ DUMC; T-Cell Functionality as Measured by ELISpot and Flow Cytometry Is Maintained Ov.  Aids Research and Human Retroviruses. A55-A55. 2011
  • Efficacy of HIV Vaccine Candidate in Macaques Dependent on the Dose of SIVmac251 Challenge Exposure: Immune Correlates of Vaccine Efficacy.  Aids Research and Human Retroviruses. A111-A111. 2011
  • HIV Neutralization in Breast Milk Mirrors that of Plasma and Is Mainly Mediated by IgG Antibodies.  Aids Research and Human Retroviruses. A72-A72. 2011
  • HIV-1 gp120 V1V2-Scaffolds for Structural Analysis and Immunogen Design.  Aids Research and Human Retroviruses. A7-A8. 2011
  • Identification of Amino Acid Residues in HIV-1 Envelope Targeted by Plasma Broadly Neutralizing Antibodies using Evolutionary Models.  Aids Research and Human Retroviruses. A15-A16. 2011
  • Influence of NK Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization.  Aids Research and Human Retroviruses. A17-A17. 2011
  • Isolation of CD4-Binding Site and V2/V3 Conformational (Quaternary) Broadly Neutralizing Antibodies from the Same HIV-1 Infected African Subject.  Aids Research and Human Retroviruses. A120-A120. 2011
  • Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects.  Aids Research and Human Retroviruses. A66-A66. 2011
  • Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses.  Aids Research and Human Retroviruses. A13-A13. 2011
  • Ontogeny, Breadth, and Specificity of Circulating ADCC-Mediating Antibodies in HIV-1 Infected Individuals.  Aids Research and Human Retroviruses. A66-A67. 2011
  • Profiles of Neutralizing Antibody Responses in Chronically HIV-1 CRF07_BC Infected Intravenous Drug Users in Western China.  Aids Research and Human Retroviruses. A46-A47. 2011
  • Structural Basis for VRC01-Like-Antibody Recognition of Variable Loops that Surround the Site of CD4 Attachment on HIV-1 Gp120.  Aids Research and Human Retroviruses. A120-A120. 2011
  • Structures of HIV-1 Quaternary-Structure-Preferring Antibodies, CH04 And PG9, Show Conserved Structural Elements Within a Generallly Flexible CDR H3.  Aids Research and Human Retroviruses. A118-A119. 2011
  • Surface Plasmon Resonance Analysis of Anti-gp120 V2-Specific IgG Antibodies Generated in the RV144 Thai Trial.  Aids Research and Human Retroviruses. A21-A22. 2011
  • The CD8+T Cell Antiviral Inhibitory Activity Predicts the Rate of CD4+Cell Decline in Early HIV-1 Infection and Is Independent of Viral Subtype.  Aids Research and Human Retroviruses. A91-A91. 2011
  • Titered Mucosal Challenge of Rhesus Macaques with SIVmac251 Recapitulates HIV Vaccine Efficacy in Humans.  Aids Research and Human Retroviruses. A4-A4. 2011
  • V2-Reactive Antibodies in RV144 Vaccinees' Plasma.  Aids Research and Human Retroviruses. A21-A21. 2011
  • Whole Blood Transcriptional Monitoring of Acute HIV-1 Infection Reveals Differential Signatures of Host Immune Activation.  Aids Research and Human Retroviruses. A34-A34. 2011
  • Antigenicity and immunogenicity of transmitted/founder HIV envelope oligomers compared to chronic HIV envelopes.  Aids Research and Human Retroviruses. A26-A26. 2010
  • Beta-arrestin and G Protein-Coupled Receptor Kinase 6 Mediates MAPK Signaling and Cellular Growth in Response to Oxytocin.  Journal of Women'S Health (2002). 1784-1784. 2010
  • Computationally identified mutations suspected to cause gp120 charge inversion and gp41-mediated allosteric effects impact IgG1b12 susceptibility.  Aids Research and Human Retroviruses. A27-A27. 2010
  • Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane proximal external region.  Aids Research and Human Retroviruses. A166-A166. 2010
  • DNA and combination vaccines achieve high levels of long lasting and protective cellular and humoral responses.  Aids Research and Human Retroviruses. A123-A124. 2010
  • Decrease in the Ratio of Infectious to Total Virions During Acute HIV-1 Infection.  Aids Research and Human Retroviruses. A13-A13. 2010
  • Early Appearance of ADCC- and ADCVI-mediating Antibody Responses Against Autologous HIV-1 Transmitted/Founder Virus.  Aids Research and Human Retroviruses. A12-A12. 2010
  • Early plasma B cell responses to transmitted HIV-1 are directed to envelope gp41 and originate by the activation of mutated B cell clones.  Aids Research and Human Retroviruses. A23-A23. 2010
  • Effect of Fc gamma-receptor polymorphisms in rhesus macaques on SIVmac251 setpoint viremia.  Aids Research and Human Retroviruses. A20-A20. 2010
  • Epitope Specificities of Elite Neutralizing Sera from HIV-1-Infected Individuals.  Aids Research and Human Retroviruses. A24-A24. 2010
  • Evidence against phagocytosis in Fc gamma RI-mediated HIV neutralization by MPER antibodies in TZM-bl cells.  Aids Research and Human Retroviruses. A152-A152. 2010
  • Evolution of the Same HIV-1 Transmitted/Founder Virus in Two Hosts.  Aids Research and Human Retroviruses. A144-A144. 2010
  • Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B.  Aids Research and Human Retroviruses. A70-A70. 2010
  • Genome-wide Association Study for HIV-1 Heterosexual Acquisition and Plasma HIV Set Point Among African Serodiscordant Couples.  Aids Research and Human Retroviruses. A158-A158. 2010
  • High magnitude and multifunctionality epitope-specific CD8+T-cell responses are associated are associated with selection of escape mutants in acute HIV infection.  Aids Research and Human Retroviruses. A5-A6. 2010
  • High titers of cross-clade ADCC-mediating antibodies are detectable in plasma samples collected from individuals with broadly neutralizing antibodies.  Aids Research and Human Retroviruses. A20-A21. 2010
  • Identification of B-chronic lymphocytic leukemia unmutated IgM germline antibodies that react with HIV-1 envelope gp41 epitopes.  Aids Research and Human Retroviruses. A57-A57. 2010
  • Immunoregulation of HIV-1 broadly neutralizing antibody responses: deciphering maturation paths for antibody induction.  Aids Research and Human Retroviruses. A153-A153. 2010
  • Improved DNA vaccination achieves long-lasting immune responses in macaques.  Aids Research and Human Retroviruses. A120-A121. 2010
  • Improvement of humoral immune responses in macaques using DNA/viral particle combination vaccine.  Aids Research and Human Retroviruses. A118-A118. 2010
  • Induction of antibodies with specificity for gp41 neutralizing epitopes by membrane anchored gp41 immunogens.  Aids Research and Human Retroviruses. A64-A64. 2010
  • Isolation of Human Monoclonal Antibodies from HIV-Uninfected Subjects Immunized with gp120/NefTat/AS01B by Dual-Color Antigen-Specific B Cell Sorting.  Aids Research and Human Retroviruses. A15-A15. 2010
  • Limited introductions and genetic variation of HIV-1 in a MSM cohort in China.  Aids Research and Human Retroviruses. A144-A144. 2010
  • Local production of HIV variants in breast milk of chronically HIV-infected, lactating women.  Aids Research and Human Retroviruses. A148-A148. 2010
  • Low Dose Mucosal SIV Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys.  Aids Research and Human Retroviruses. A29-A29. 2010
  • Magnitude and Breadth of the Neutralizing Antibody Response in RV144.  Aids Research and Human Retroviruses. A161-A161. 2010
  • Molecular targets and potency of HIV-1 neutralization revealed by dynamic assessment of transmitted/founder virus antibody recognition and escape.  Aids Research and Human Retroviruses. A11-A12. 2010
  • Neutralizing antibody responses to HIV-1 are dependent on conformational integrity of gp140 immunogens.  Aids Research and Human Retroviruses. A50-A50. 2010
  • New broadly neutralizing human monoclonal antibodies targeting the 2F5 epitope.  Aids Research and Human Retroviruses. A14-A15. 2010
  • Profiles of neutralizing antibody responses in chronically HIV-1 clade B' infected treatment-naive former plasma donors in China.  Aids Research and Human Retroviruses. A44-A46. 2010
  • Rapid and high throughput strategy for expressing human monoclonal antibodies and generating of antibody-expression stably transfected cell lines.  Aids Research and Human Retroviruses. A54-A54. 2010
  • Reverted unmutated ancestor 2F5 VH2-5 alleles differentially bind gp41 and bacterial proteins: a genetic basis for gp41 neutralizing B cell responses.  Aids Research and Human Retroviruses. A154-A155. 2010
  • Role of immunoglobulin light chain usage and MPER specificity in counterselecting B cells expressing the broadly neutralizing antibody 2F5.  Aids Research and Human Retroviruses. A154-A154. 2010
  • SIV-Specific Cytotoxic CD4+T Cells and Humoral Responses Control Rebounding Viremia in CD8-Depleted Macaques Infected with Rev-Independent SIV.  Aids Research and Human Retroviruses. A112-A112. 2010
  • The B cell repertoire of terminal ileum in HIV-1 infection: concentration of antigen-reactive cells in the plasma cell versus the memory B cell pool.  Aids Research and Human Retroviruses. A159-A159. 2010
  • Vaccine-Elicited IgG Subclasses and Functional Antibodies.  Aids Research and Human Retroviruses. A157-A157. 2010
  • A NOVEL CO2-LASER PARTIAL NEPHRECTOMY: PILOT STUDY IN A PORCINE MODEL.  Journal of Endourology. A13-A13. 2010
  • CONTRAST ENHANCEMENT AFTER RENAL CRYOABLATION: AN EVIDENCE OF TREATMENT FAILURE?.  Journal of Endourology. A236-A237. 2010
  • FACTORS AFFECTING PATIENT RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMY.  Journal of Endourology. A269-A269. 2010
  • FACTORS AFFECTING RADIATION EXPOSURE DURING URETEROSCOPY.  Journal of Endourology. A83-A83. 2010
  • IN VITRO ASSESSMENT OF FRAGMENTATION AND RETROPULSION IN A NEW PNEUMATIC LITHOTRIPSY DEVICE.  Journal of Endourology. A7-A7. 2010
  • IN VIVO STONE FRAGMENTATION AND TISSUE INJURY PRODUCED BY A NEW ACOUSTIC LENS FOR A SIEMENS LITHOTRIPTER.  Journal of Endourology. A20-A20. 2010
  • OPTIMIZATION OF TREATMENT STRATEGY EMPLOYED DURING SWL TO MAXIMIZE STONE FRAGMENTATION EFFICIENCY.  Journal of Endourology. A19-A19. 2010
  • ORGAN SPECIFIC RADIATION DOSE DURING PERCUTANEOUS NEPHROLITHOTOMY.  Journal of Endourology. A79-A79. 2010
  • ORGAN SPECIFIC RADIATION DOSE RATE FOR PERCUTANEOUS NEPHROLITHOTOMY IN A VALIDATED MODEL.  Journal of Endourology. A78-A78. 2010
  • REDUCED RADIATION EXPOSURE WITH THE USE OF AN AIR RETROGRADE PYELOGRAM DURING FLUOROSCOPIC ACCESS FOR PERCUTANEOUS NEPHROLITHOTOMY.  Journal of Endourology. A147-A147. 2010
  • SURGICAL EXPERIENCE AFFECTS APICAL SURGICAL MARGINS STATUS IN ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY INDEPENDENTLY FROM DISEASE CHARACTERISTICS.  Journal of Endourology. A101-A101. 2010
  • SURGICAL STEPS ELONGATING OPERATIVE TIME IN ROBOTIC ASSISTED RADICAL PROSTATECTOMY AMONG THE OBESE POPULATION.  Journal of Endourology. A45-A45. 2010
  • THE ROLE OF ENDOSCOPIC NEPHRON-SPARING SUREGY IN THE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA.  Journal of Endourology. A264-A265. 2010
  • USE OF HEMOSTATIC AGENTS IN PERCUTANEOUS NEPHROLITHOTOMY TRACTS REDUCES URINE LEAK RATE IN A PORCINE MODEL.  Journal of Endourology. A19-A19. 2010
  • WHAT FACTORS CAN BETTER PREDICT THE INCIDENCE OF UROSEPSIS FOLLOWING AN ACUTE STONE EPISODE?.  Journal of Endourology. A179-A179. 2010
  • HTLV-II Establishes a Persistent Infection in Rhesus Macaques and Does Not Exacerbate SIV Infection.  Aids Research and Human Retroviruses. 1212-1212. 2009
  • DEFORMATION THRESHOLD FOR AXONAL INJURY IS LARGER IN TODDLER THAN INFANT PIGS.  Journal of Neurotrauma. A84-A84. 2009
  • RAPID SAGITTAL ROTATIONS PRODUCE MORE SEVERE PHYSIOLOGICAL AND HISTOPATHOLOGICAL RESPONSES IN NEONATAL PIGLETS THAN CORONAL OR HORIZONTAL ROTATIONS.  Journal of Neurotrauma. A22-A22. 2009
  • SEVERITY OF EXTRA-AXIAL HEMORRHAGE FROM NON-IMPACT INERTIAL HEAD ROTATION IN THE IMMATURE PIG VARIES WITH DIRECTION.  Journal of Neurotrauma. A86-A86. 2009
  • 2F5-Like Antibody Identified from an HIV-Infected Patient Concurrent with the Development of Autoimmune Antibodies.  Aids Research and Human Retroviruses. 53-54. 2008
  • All Known Cross-Reactive HIV-1 Neutralizing Antibodies are Highly Divergent from Germline and Their Elicitation May Require Prolonged Periods of Time.  Aids Research and Human Retroviruses. 11-12. 2008
  • Anti-lipid Human Monoclonal Antibodies Inhibit HIV-1 Infection of PBMC by Binding to Host Cells.  Aids Research and Human Retroviruses. 13-13. 2008
  • Characterisation of the Genetic Bottle-Neck in HIV-1 Subtype C, Heterosexually Infected Men and Women from Malawi and South Africa.  Aids Research and Human Retroviruses. 35-35. 2008
  • Covalent gp120 Immunization: Induction of Neutralizing Monoclonal Antibodies but Failure to Enhance Vaccine-Relevant Polyclonal Antibody Activity.  Aids Research and Human Retroviruses. 56-56. 2008
  • Detection of Cross-Clade T- and B-Cell-Mediated Immune Responses among HIV-1 Infected Individuals in Northern Tanzania.  Aids Research and Human Retroviruses. 92-92. 2008
  • Enhanced Neutralization of HIV-1 by gp41 MPER-Specific Antibodies in Cells that Express Fcg Receptors.  Aids Research and Human Retroviruses. 11-11. 2008
  • Establishing PBMC Repository for T Cell Assays Optimization and Proficiency Testing in CTC-VIMC Laboratories.  Aids Research and Human Retroviruses. 127-128. 2008
  • Exceptionally Potent, Broadly-Neutralizing IgAs from Survivors of Prolonged HIV Infection.  Aids Research and Human Retroviruses. 55-55. 2008
  • Functional Analysis of the Quasispecies env Population in Individuals Infected with HIV-1 Subtype C Viruses.  Aids Research and Human Retroviruses. 158-158. 2008
  • Functional Comparison of HIV-1 env Gene Quasispecies Populations from Acutely and Chronically Infected Individuals.  Aids Research and Human Retroviruses. 37-38. 2008
  • Generation of Robust Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) Antigens.  Aids Research and Human Retroviruses. 24-25. 2008
  • HIV-1 Immune Complexes are part of the Initial B cell Response in Acute HIV-1 infection.  Aids Research and Human Retroviruses. 54-54. 2008
  • Highly Complex Neutralization Determinants on a Monophyletic Lineage of Newly Transmitted Subtype C HIV-1 Env Clones from India.  Aids Research and Human Retroviruses. 48-49. 2008
  • Identification of Transmitted/Founder Complete HIV-1 Genomes in Subjects with Acute HIV-1 Infection.  Aids Research and Human Retroviruses. 4-5. 2008
  • Immunogenicity and Neutralization Properties of a Trimeric MPER Containing gp41 Antigen.  Aids Research and Human Retroviruses. 97-97. 2008
  • Improved Induction of Antibodies against Key Neutralizing Epitopes by HIV-1 gp120 DNA Prime-Protein Boost Compared to gp120 Protein Only Vaccination.  Aids Research and Human Retroviruses. 45-45. 2008
  • Interferon-gamma Responses to HIV-1 Clade A and D Peptides in Ugandan Serodiscordant Couples - the CHAVI 002 Protocol.  Aids Research and Human Retroviruses. 130-130. 2008
  • Lack of Highly Poly-Functional Epitope-Specific CD8+Memory T Cell Responses during Spontaneous Control of Viremia.  Aids Research and Human Retroviruses. 20-20. 2008
  • Microparticles and Apoptotic Cells Generated from Apoptotic T Cells Inhibit Human Dendritic Cell Cytokine Production.  Aids Research and Human Retroviruses. 82-82. 2008
  • Pattern of HIV-1-gp41 Binding and Neutralizing Antibodies in Subtype C Infected Women and in their HIV-1-Seronegative Neonates.  Aids Research and Human Retroviruses. 45-45. 2008
  • Perturbations of the Vb-T Cell Repertoire in HIV Uninfected Neonates Born to HIV-1 Subtype C Infected Mothers: Evidence for T Cell Priming in Utero.  Aids Research and Human Retroviruses. 124-124. 2008
  • Profile of HIV-1-env Binding and Neutralizing Antibodies in Subtype C, A and B Infected Women.  Aids Research and Human Retroviruses. 42-42. 2008
  • Recombination of HIV-1 gp160 Clones with Viral Backbone DNA through Co-transfection to Produce Pseudoviruses can Create Replication Competent Viruses.  Aids Research and Human Retroviruses. 47-48. 2008
  • T Cell Escape in Subjects with Acute HIV-1 Infection.  Aids Research and Human Retroviruses. 6-7. 2008
  • The Role of Lipid Reactivity of HIV-1 gp41 Membrane Proximal Antibodies in Neutralization of HIV-1: Novel Liposome Based Immunogen Design.  Aids Research and Human Retroviruses. 23-24. 2008
  • Regional cerebral blood flow response following brain injury depends on direction of head motion.  Journal of Neurotrauma. 923-923. 2008
  • Temporal changes in brain tissue oxygen and metabolism following diffuse traumatic brain injury in piglets.  Journal of Neurotrauma. 886-886. 2008
  • Alveolar bone regeneration in a gingivoperiosteoplasty model.  Tissue Engineering. Part A. 806-807. 2008
  • Carrier-filled solid scaffolds with time-released porosity for endogenous bone engineering.  Tissue Engineering. Part A. 817-818. 2008
  • Dynamic cell culture prevents core necrosis and creates meaningful osteoblastic networks in thick 3D tissue-engineered constructs.  Tissue Engineering. Part A. 840-841. 2008
  • Home, sweet home: Recreating the native bony environment in vitro using a novel dynamic cell-culture system for bone-biology research.  Tissue Engineering. Part A. 740-740. 2008
  • Multi-tiered sequential processing and analysis of 3D tissue-engineered constructs.  Tissue Engineering. Part A. 758-758. 2008
  • Assessment of citrate concentrations in citrus fruit-based juices and beverages: Implications for management of hypocitraturic nephrolithiasis.  Journal of Endourology. A5-A6. 2007
  • Calcium phosphate content increases after citrate therapy in patients with recurrent urinary lithiasis.  Journal of Endourology. A250-A250. 2007
  • New stone holders for in-vitro characterization of shock wave lithotripters.  Journal of Endourology. A247-A248. 2007
  • Prostate cancer laterality as a rationale for the clinical application of focal ablative therapy: An analysis of 1184 prostatectomy specimens.  Journal of Endourology. A216-A216. 2007
  • The Escape(tm) nitinol stone retrieval basket facilitates laser fragmentation and extraction of ureteral and large renal calculi: Initial experience.  Journal of Endourology. A13-A14. 2007
  • The case of the disappearing stent and the stent density-time continuum.  Journal of Endourology. A254-A254. 2007
  • The effect of beam size on stone comminution in SWL.  Journal of Endourology. A246-A246. 2007
  • Tumor laterality does not predict biochemical prostate cancer recurrence after radical prostatectomy.  Journal of Endourology. A216-A216. 2007
  • Severity of damage following inertial brain injury depends on direction of head rotation.  Journal of Neurotrauma. 1272-1272. 2007
  • The NUgene Project: Biospecimen informatics system design.  Cell Preservation Technology. 230-231. 2006
  • The NUgene Project: eMR-facilitated biobanking.  Cell Preservation Technology. 232-232. 2006
  • A retrospective analysis of hand-assisted laparoscopic nephroureterectomy for upper tract urothelial carcinoma.  Journal of Endourology. A164-A164. 2006
  • Changing practice patterns for the surgical management of renal calculi.  Journal of Endourology. A114-A114. 2006
  • Complications in laparoscopic surgery for urological cancer.  Journal of Endourology. A6-A6. 2006
  • Digital video ureteroscopy: The new paradigm.  Journal of Endourology. A302-A302. 2006
  • Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: A randomized, controlled study.  Journal of Endourology. A34-A34. 2006
  • Evaluation of 24-hour urinary parameters in nonstone forming children.  Journal of Endourology. A145-A145. 2006
  • Evaluation of marcaine administration for post operative pain after percutaneous nephrolithotomy.  Journal of Endourology. A23-A23. 2006
  • In vitro comparison of electrohydraulic and electromagnetic shock wave lithotripters.  Journal of Endourology. A83-A83. 2006
  • Second generation radial-dilating ureteral access sheath compared to a standard access sheath in a porcine model.  Journal of Endourology. A67-A67. 2006
  • Seven years after laparoscopic radical nephrectomy: Oncologic and renal functional outcomes.  Journal of Endourology. A205-A205. 2006
  • Training for robotic radical prostatectomy: A strategy for residents.  Journal of Endourology. A124-A124. 2006
  • Hypertonic saline increases cerebral blood flow after traumatic brain injury.  Journal of Neurotrauma. 1024-1024. 2006
  • Aging's adverse relationship with traumatic brain injury outcome: Does neuroinflammation play a role?.  Journal of Neurotrauma. 1206-1206. 2005
  • Apolipoprotein E polymorphism and spinal cord injury outcomes.  Journal of Neurotrauma. 1237-1237. 2005
  • Direction dependence of rotational accelerational injury on cerebrovascular hemodynamics response depends on direction of angular acceleration.  Journal of Neurotrauma. 1254-1254. 2005
  • Changing gender prevalence of nephrolithiasis.  Journal of Endourology. A6-A6. 2005
  • Digital video ureteroscope: A new paradigm in ureteroscopy.  Journal of Endourology. A80-A80. 2005